Efficacy of Fractional CO2 Laser in the Treatment of Macular Amyloidosis

Authors

  • Fouz Hassan Tishreen Journal
  • Batoul Mouhammad

Abstract

Background: Macular amyloidosis is considered a common cutaneous disease, and cosmetic disorder. It's an unpleasant for patients especially when accompanied by sever itching. Despite the presence of various therapeutic modalities, none is considered curative or satisfactory, in addition to their side effects.

Objective: Evaluate effectiveness of fractional co2 laser in the treatment of macular amyloidosis.

Patients and Methods: Before & After Study (prospective) was conducted on 35 female patients with macular amyloidosis were treated with 4 sessions of fractional co2 laser with 4 weeks interval, followed by topical corticosteroid under occlusion for 24 hours (Betamethasone Valerate 0.1%). Treatment energy parameters have been remained constant in all sessions (15 watts). Improvement was evaluated using color grading scale before the first session and one month after the last session. We also evaluate degree of itching on scale from 0 to 10. In addition to evaluate resulting side effects after every session. Recurrence was reported as well, during the follow up period (three months after the last session).

Downloads

Published

2020-10-01

How to Cite

1.
حسن ف, محمد ب. Efficacy of Fractional CO2 Laser in the Treatment of Macular Amyloidosis. Tuj-hlth [Internet]. 2020Oct.1 [cited 2024Apr.20];42(4). Available from: https://journal.tishreen.edu.sy/index.php/hlthscnc/article/view/9870

Issue

Vol. 42 No. 4 (2020): Tishreen University Journal for Research and Scientific Studies - Medical Sciences Series

Section

Articles

License

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

The authors retain the copyright and grant the right to publish in the magazine for the first time with the transfer of the commercial right to Tishreen University Journal for Research and Scientific Studies - Health Sciences Series

 Under a CC BY- NC-SA 04 license that allows others to share the work with of the work's authorship and initial publication in this journal. Authors can use a copy of their articles in their scientific activity, and on their scientific websites, provided that the place of publication is indicted in  Tishreen University Journal for Research and Scientific Studies - Health Sciences Series   .  The Readers have the right to send, print and subscribe to the initial version of the article, and the title of  Tishreen University Journal for Research and Scientific Studies - Health Sciences Series  Publisher

journal uses a CC BY-NC-SA license which mean

You are free to:

  • Adapt — remix, transform, and build upon the material
  •  
  • The licensor cannot revoke these freedoms as long as you follow the license terms.

 

  • Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
  • NonCommercial — You may not use the material for commercial purposes.
  • ShareAlike — If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.
  • No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.

Most read articles by the same author(s)

1 2 > >>